cgm.com
CompuGroup Medical provides software solutions for healthcare sectors worldwide, supporting over 1.6 million professional users and operating in 60 countries with approximately 9,200 employees.
Global Operations of CompuGroup Medical
CompuGroup Medical operates in 60 countries worldwide. With a significant global presence, the company employs approximately 9,200 employees, highlighting its extensive reach in the healthcare software solutions industry. This global scale enables CompuGroup Medical to serve a vast array of clients in various regions, catering to the diverse needs of different healthcare systems.
CompuGroup Medical Software Solutions
CompuGroup Medical offers a range of software solutions tailored for various sectors including hospitals, laboratories, pharmacies, and ambulatory care. The company's software supports over 1.6 million professional users, underlining its integral role in streamlining operations and improving efficiency within the healthcare industry. Notably, the CGM Clinical software is utilized in hospital projects related to the Hospital Future Act.
Financial Performance of CompuGroup Medical in 2024
In the first quarter of 2024, CompuGroup Medical reported a 2% decrease in revenues compared to the prior year. However, organic revenue growth was positive at 3% when adjusted for one-off effects. The HIS segment revenues grew by 7% to EUR 78 million, and the PCS segment saw recurring revenues increase by 6% to EUR 25 million. The AIS segment's recurring revenues increased by 5%, representing 76% of the segment's revenues. The company's free cash flow stood at EUR 59 million after the first three months of 2024.
Key Initiatives and Operations of CompuGroup Medical
CompuGroup Medical's e-prescription system saw 113 million e-prescriptions redeemed in Germany in the first quarter of 2024. Additionally, the company's ambulatory information systems processed 41% of digital health documents in France in March 2024. In April 2024, CompuGroup Medical completed a share buyback program, acquiring 500,000 shares at a total volume of EUR 14.6 million. Furthermore, the company proposed a dividend of EUR 1.00 per share to be passed at the virtual AGM in May 2024.
CompuGroup Medical Recurring Revenue Insights
CompuGroup Medical's recurring revenue share increased to 75% in the first quarter of 2024. This highlights the company's strong foundation for sustained financial performance. The PCS segment saw its recurring revenues increase by 6% to EUR 25 million, and the AIS segment's recurring revenues increased by 5%, making up 76% of the segment's revenues. These figures underscore the significant contribution of recurring revenues to the company's overall financial health.